Navigating the Next Frontier in Metabolic Health Innovation
The Emergence of a Triple-Agonist Paradigm The landscape of pharmaceutical interventions for obesity and metabolic disorders is undergoing a seismic shift, driven by the development of multi-target therapies. Among the…